Surgical Science Sweden (SUS.ST) Stock Price
Surgical Science Sweden Price
Over the last 11 years Surgical Science Sweden grew revenue by 33.6% annually, reaching 992.34 M SEK. Earnings per share have grown at 34.9% per year over the last 10 years. For Surgical Science Sweden, the net margin of 6.7% is down versus 23.5% a few years ago. The consensus 12-month price target for Surgical Science Sweden is 61.20 SEK, about 12.9% above where the stock trades today. Of 8 analysts, 5 rate the stock a buy — an overall Buy consensus.
Surgical Science Sweden stock price
Surgical Science Sweden business model & stock analysis
Frequently asked questions about Surgical Science Sweden
The business model of Surgical Science Sweden AB revolves around providing advanced medical simulation solutions. As a leading global supplier, Surgical Science focuses on developing and delivering high-fidelity simulators and software tools for medical training and education. These simulation solutions enable medical professionals to practice surgical procedures and enhance their skills in a safe and realistic environment. With a strong commitment to innovation and educational excellence, Surgical Science Sweden AB aims to improve patient safety and quality of care by offering state-of-the-art simulation technology to healthcare institutions and professionals worldwide.
Surgical Science Sweden AB is primarily active in the healthcare industry.
The main competitors of Surgical Science Sweden AB in the market include other companies operating in the medical simulation industry. These competitors may include Simulab Corporation, CAE Healthcare, Mentice AB, and Limbs & Things Ltd. These companies offer similar products and solutions for medical training and simulation purposes, competing with Surgical Science Sweden AB in terms of product quality, pricing, and market share. Surgical Science Sweden AB strives to maintain its competitive edge by continually innovating and delivering high-quality medical simulation technology to its customers.
Surgical Science Sweden AB is a company with a rich history and background. Established in Sweden, the company has been a prominent player in the field of surgical simulation and training since its inception. With a focus on providing realistic and immersive training solutions for medical professionals, Surgical Science Sweden AB has developed cutting-edge technology and advanced simulators. Over the years, the company has gained recognition for its innovation, quality, and commitment to improving surgical education. With a strong presence in the global market, Surgical Science Sweden AB continues to lead the way in revolutionizing surgical training, ensuring safer and more efficient procedures for healthcare professionals worldwide.
Surgical Science Sweden AB has achieved significant milestones in its journey. The company has made remarkable advancements in the field of surgical simulation, providing cutting-edge training solutions to medical professionals worldwide. Surgical Science Sweden AB has received recognition for its high-quality simulators, which offer a realistic and immersive experience for trainees. The company's commitment to innovation has led to partnerships with renowned medical institutions, paving the way for research collaborations and improved training methods. Additionally, Surgical Science Sweden AB has expanded its global presence, establishing itself as a leader in surgical education.
Surgical Science Sweden AB is primarily present in several countries and regions worldwide. The company has a global presence, with a strong focus on Scandinavia, Europe, North America, and Asia. Surgical Science Sweden AB has established partnerships and collaborations with numerous medical institutions, universities, and healthcare providers in these regions, ensuring the widespread availability and adoption of their cutting-edge surgical simulators and training solutions. With their commitment to excellence and innovation, Surgical Science Sweden AB continues to expand its reach, delivering advanced medical training technology to professionals in various countries and regions across the globe.
Surgical Science Sweden AB represents a set of core values and corporate philosophy that drive its operations. The company prioritizes excellence in healthcare simulation technology, aiming to enhance medical training and patient safety worldwide. Surgical Science Sweden AB is committed to providing innovative and advanced solutions for surgical education, offering realistic simulators that mimic the human anatomy and empower medical professionals to develop their skills and expertise. With a focus on quality, the company strives for continuous improvement and collaboration with industry partners, ensuring its products are at the forefront of medical simulation. Surgical Science Sweden AB's dedication to delivering superior training tools makes it a trusted leader in the field.
Analysts currently set an average price target of 63.24 SEK for the Surgical Science Sweden stock (median: 61.20 SEK), implying +16.7 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Surgical Science Sweden stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Surgical Science Sweden to generate revenue of 1.02 B SEK and earnings per share of 2.14 SEK.
Converted at the current exchange rate, the Surgical Science Sweden share trades at 4.86 EUR (54.20 SEK).
The Surgical Science Sweden share (SUS.ST) is listed on 7 stock exchanges, including: London (0AAU.L), Frankfurt (4P41.F), München (4P41.MU), Düsseldorf (4P41.DU), Stockholm (SUS.ST).
The company Surgical Science Sweden AB is an innovative company in the field of medical education. Founded in 1999, the company aims to improve the training of medical personnel by producing realistic simulators. The company places great emphasis on attention to detail and realistic simulation in order to ensure a high training quality. Surgical Science Sweden AB's business model is based on three areas of business: 1. Medical simulators Surgical Science Sweden AB produces a wide range of medical simulators that support the training of medical personnel in various areas. These include simulators for endovascular procedures, minimally invasive procedures, anesthesia, and resuscitation. The simulators are designed to be realistic and equipped with various scenarios to provide an effective training experience. 2. Training programs In addition to manufacturing medical simulators, Surgical Science Sweden AB also offers training programs tailored to the respective simulators. The training is provided by experienced instructors who support trainees in working with the simulators and provide feedback on their training. These training programs are an effective way to bring medical personnel up to date with the latest technology or acquire specific skills. 3. Maintenance and support Surgical Science Sweden AB also offers maintenance and support services for its medical simulators. These services are important to ensure that the simulators are always in perfect condition and ready for use at any time. In addition, the company also offers training in the use of the simulators and first-class technical support. Overall, Surgical Science Sweden AB has developed an innovative business model based on the production of realistic medical simulators, while also enabling high-quality training for medical personnel. The company has achieved its market position through a consistent focus on quality and innovation. The simulators from Surgical Science Sweden AB are used in leading medical training institutions worldwide, contributing to the improvement of medical personnel training and patient safety.
The expected revenue of Surgical Science Sweden is 1.02 B SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Surgical Science Sweden is 109.45 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Surgical Science Sweden is currently 25.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Surgical Science Sweden stock.
The price-to-sales ratio (P/S) of Surgical Science Sweden is currently 2.71. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Surgical Science Sweden stock.
The Eulerpool Quality Score for Surgical Science Sweden is 6/10.
The ISIN of Surgical Science Sweden is SE0014428512. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Surgical Science Sweden is A2P46G. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Surgical Science Sweden is SUS.ST. The ticker symbol is used to trade Surgical Science Sweden shares on the stock exchange.
Surgical Science Sweden stock
Surgical Science Sweden Peer Group
Surgical Science Sweden Ticker
Surgical Science Sweden FIGI
All fundamentals and in-depth analysis of Surgical Science Sweden
Our stock analysis for Surgical Science Sweden stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.